Airfreight digital booking portal WebCargo can now directly process real-time rates and payments for forwarders and airlines, enabling forwarders to pay for bookings on the platform rather than using a separate tool, Air Cargo News reported on Friday (May 27). Read...
Read More
Top investment opportunitiesStartup of the Week: Convizit, making user experience a snapLetter from Davos: FoodTech steps up to the plateWhy Oprah loves Tovala’s smart ovenForbes reveals Mermade’s cultivated seafood secretStream now: Investing in the Circular EconomyMicrosoft picks Maolac and Trellis for AI programCan Profuse transform the costs of lab-grown meat?New York State to hand out 800+ ElliQ robots to elderly Kim Kardashian gives Beyond Meat a bounceTaranis gives farmers a down-to-earth view of crops from aboveIsrael plans to invest $180M to develop civilian space techArcadia acquires world’s largest utility data provider, raises $200M IntroductionsMore than 4,200 high-tech jobs Startup of the Week:Convizit: Making user experience a snap Millions of applications are driven by software tools that understand and improve customers’ digital experience, but capturing the relevant data isn’t easy. Every action needs to be manually recorded, which is an expensive and inefficient proposition. Our portfolio company Convizit uses a suite of AI technologies to automatically capture and understand each user event on every webpage. The company’s machine-learning platform understands how consumers see webpages and improves its automatic-tagging abilities over...
Read MoreOne of the oldest debates in history—privacy versus security—is undergoing a postmodern update—with privacy advocates accusing Tesla of enabling the invasion of privacy via its built-in camera-based security system. Read...
Read MoreLARKSPUR, Calif.–(BUSINESS WIRE)– Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through the development of potentially best-in-class IL-2 therapeutics, today shared a Trials in Progress poster that is being presented at the American Society of Clinical Oncology (ASCO) 2022 Annual Meeting. The poster showcases the study design for the company’s first-in-human Phase 1/2 trial of AU-007 that is currently enrolling patients in Australia. AU-007 is a human monoclonal antibody computationally designed by Biolojic Design, with a highly differentiated approach to harnessing the power of interleukin-2 (IL-2) to eradicate solid tumors. Read...
Read MoreThe burgeoning Druid Hills tennis center in Atlanta is the latest to implement PlaySight Interactive’s connected-camera technology to boost its coaching and player development. Read more...
Read More
